Are poison pills really that bitter?

Equity

TechCrunch

Entrepreneurship, Business News, News, Business, Technology

4.2 • 372 Ratings

🗓️ 18 April 2022

⏱️ 9 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Every Monday, Grace and Alex scour the news and record notes on what’s going on to kick off the week. We are sitting on the precipice of a very busy few weeks, so let's get right to work! Stocks are mixed around the world to start the day, cryptos are off a little more but nothing too scary. Didi will vote on leaving the US public markets this May, and has promised to not list anywhere else in the interim. This saga is nearly behind us, but what a mess it will leave in its wake. The Beanstalk exploit was bad news this weekend, but my hunch is that so long as votes are tied to economic might, many neat ideas in crypto-land will remain open to exploit. Zambian fintech startup Union54 raised a $12 million Seed extension, led by Tiger, that caught our eye. And over in India, food-delivery rivals Swiggy and Zomato are both backing UrbanPiper. Finally, it seems that some private-market investors are not stoked about poison pills, a defensive setup by public companies to prevent a hostile takeover. Which makes me laugh, as dual-class shares that many VCs either back, or at least help fund amongst hot startups are similar in that they are also designed to prevent changes of control. To close, we have a live show this week! Yes, a live show. So come hang out with us on Thursday as we record our Friday episode! Credits: Equity is produced by Theresa Loconsolo with editing by Kell. Bryce Durbin is our Illustrator. We'd also like to thank the audience development team and Henry Pickavet, who manages TechCrunch audio products. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	Hello and welcome back to Equity, the Tech Runge Podcast,
0:12.7	where we unpack the numbers and the new ones behind the headlines.
0:15.8	This is Alex, and it is April 18th, 2022,
0:18.9	and I am proud to say that I am back in Providence,
0:21.1	where I belong, which means I have my full setup and I cannot
0:23.7	wait to have a very very productive week but first guys the markets.
0:27.0	Taking a look at the markets what's going on. Well over in the European Union stocks are up.
0:34.8	Over in Asia stocks were mixed today. China's first quarter GDP data did come in better than expected,
0:39.8	but don't forget it's not really inclusive of the Shanghai lockdown, so more to come there.
0:44.8	Here in the US stocks are down a little bit ahead of the open, but nothing too crazy.
0:49.2	Turning our eyes to the crypto market, well, major crypto tokens are down in the last 24 hours and about 5% in the last week,
0:56.2	but if you prefer that data in dollar terms, well, Bitcoin is back under the $40,000 mark,
1:01.2	well, Eith has slumped back under 3K.
1:03.8	tokens from Salana and other smaller chains are off more like 8% in the last seven days,
1:08.1	but really not too much is going on this morning.
1:10.7	However, a lot is about to happen looking ahead in the market's context.
1:14.2	We do have earnings this week, which of course has me incredibly excited.
1:18.2	We're going to hear from Netflix, Snap, Qualtrix, and Tesla this week, but really, it's all
1:22.4	prelude to what's coming next week, which is,
1:24.7	Google, Microsoft, Facebook, Apple Spot.
1:28.6	It's going to be absolutely packed.
1:30.0	So the next two weeks, lots of data get hyp.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from TechCrunch, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of TechCrunch and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.